USPH Form 144: Insider Notice to Sell 700 Shares ($60,119)

US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119.

Rhea-AI Filing Summary

US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119. It shows total shares outstanding of 15,204,119, indicating the proposed sale represents a very small fraction of the companys outstanding stock. The shares were acquired on 01/01/2025 as employee equity compensation (1,208 shares reported acquired). The filer reports no sales in the past three months.

Insights

Securities Analyst

TL;DR: Small insider sale notice; amount is immaterial relative to outstanding shares.

The Form 144 notifies the market of a proposed sale of 700 shares valued at $60,119 via Charles Schwab with an approximate trade date of 08/25/2025. Against 15.2 million shares outstanding, the position is negligible, suggesting limited market impact. The securities were acquired as employee equity compensation on 01/01/2025. No prior sales in the past three months are reported, which reduces concerns about accelerated insider liquidation.

Compliance/Risk Analyst

TL;DR: Filing appears routine and compliant; standard attestation included.

The notice includes the required attestation that the seller is not aware of undisclosed material adverse information and references the Rule 10b5-1 plan language. Broker details and acquisition method are disclosed, and the filing indicates no recent sales to aggregate. From a compliance perspective, the form contains the standard disclosures expected for an insider sale arising from equity compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does USPH's Form 144 disclose about the planned insider sale?

The Form 144 discloses a proposed sale of 700 shares of USPH common stock through Charles Schwab with an approximate sale date of 08/25/2025 and an aggregate market value of $60,119.

How large is the proposed sale relative to USPH outstanding shares?

The filing reports 15,204,119 shares outstanding; the proposed sale of 700 shares represents approximately 0.0046% of outstanding shares.

When and how were the shares being sold acquired?

The shares were acquired on 01/01/2025 as employee equity compensation, with 1,208 shares reported acquired on that date.

Did the filer report any sales of USPH securities in the prior three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 include standard attestations about material information?

Yes. The filer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 trading plan language.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/25/2025 - 11:03 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001482760
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	U S PHYSICAL THERAPY INC /NV
SEC File Number	001-11151
Address of Issuer	1300 WEST SAM HOUSTON PARKWAY SOUTH SUITE 300 HOUSTON TEXAS 77042
Phone	7132977000
Name of Person for Whose Account the Securities are To Be Sold	HENDRICKSON CAREY P
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	700	60119.00	15204119	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2025	Employee Compensation	Issuer			1208	01/01/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	2a) Carey P & Stacie G Hendrickson TEN/COM
Date of Notice	08/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Carey P. Hendrickson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)